Kuehn Law Encourages INFN, RPHM, VAPO, and PRFT Investors to Contact Law Firm PR Newswire NEW YORK, July 1...
Merger to create a Nasdaq-listed, clinical-stage biopharmaceutical company focused on advancing OnKureβs...
IRVINE, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (Nasdaq: RPHM), a pharmaceutical...
IRVINE, Calif., March 28, 2024 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (Nasdaq: RPHM), a...
SAN MATEO, Calif., March 25, 2024 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (Sagimet, Nasdaq: SGMT), a...
The STRIDE study did not meet its primary or secondary efficacy endpoint The company to suspend mavodelpar...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.